Patients with HIV who have suppressed viral loads and pre-existing resistance will be able to use bictegravir with this FDA approval. The FDA has approved an expanded indication for bictegravir ...
(RTTNews) - The U.S. Food and Drug Administration approved a new, expanded indication for Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) to treat people ...
Gilead Sciences received the Food and Drug Administration’s approval for a new, expanded indication for Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) ...
Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.
A small UCSF study has shown promising signs of a potential functional HIV cure. After receiving a mix of vaccines, ...
Following the successful conclusion of three clinical trials, approximately 120 patients continue treatment with leronlimab in extension arms VANCOUVER, Washington, May 03, 2021 (GLOBE NEWSWIRE) -- ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window "Medical ...
A Food and Drug Administration (FDA) panel is debating whether to make history by recommending approval of the first drug to prevent HIV infection. The advisory committee is expected to vote on ...
Hundreds of Arizonans continue to contract HIV every year despite numerous prevention tools, including a preventive medication. The most recently available data shows that 852 Arizonans were among ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 20th European AIDS Conference (EACS) to be held in Paris, France from October 15-18. As the leader in HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback